Zobrazeno 1 - 10
of 524
pro vyhledávání: '"Peter Rieckmann"'
Publikováno v:
Journal of NeuroEngineering and Rehabilitation, Vol 20, Iss 1, Pp 1-15 (2023)
Abstract Background Wearable technologies are currently clinically used to assess energy expenditure in a variety of populations, e.g., persons with multiple sclerosis or frail elderly. To date, going beyond physical activity, deriving sensorimotor c
Externí odkaz:
https://doaj.org/article/22337e5881ae4adfacba1c575c3511b9
Autor:
Hayder K. Hassoun, Akram Almahdawi, Sarwer Jamal Al-Bajalan, Nawfal M. Sheaheed, Mohammad A.S. Kamil, Samer Mohammed Saeed Ridha, Mazin M.H. Al-Owath, Muataz Fairooz Abd, Basim Al-Khammasi, Zaki Noah Hasan, Anmar Oday Hatem, Murad Al-Naqshbandi, Peter Rieckmann
Publikováno v:
Heliyon, Vol 9, Iss 2, Pp e13350- (2023)
Background: Multiple sclerosis (MS) is often diagnosed in women of childbearing age (WCBA), with a mean age of onset of 30 years. Women with MS have long been cautioned to carefully plan their pregnancies and, traditionally, disease-modifying therapi
Externí odkaz:
https://doaj.org/article/92eec918c3ba428c9168dea98a6291fd
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Finger tapping tests have been shown feasible to assess motor performance in multiple sclerosis (MS) and were observed to be strongly associated with the estimated clinical severity of the disease. Therefore, tapping tests could be an adequa
Externí odkaz:
https://doaj.org/article/2d5acb2849b046c1a85371f084e2e3b8
Autor:
Felix Amereller, Jochen Schopohl, Sylvère Störmann, Katharina Schilbach, Martin Bidlingmaier, Martin Fischer, Peter Rieckmann, Philipp Gulde
Publikováno v:
Case Reports in Neurology, Pp 1-1 (2023)
Although the prognosis in Guillain-Barré syndrome (GBS) is generally good, protracted and incomplete courses of recovery can be a heavy burden. Animal studies suggest growth hormone (GH) treatment could stimulate myelin repair and thus accelerate fu
Externí odkaz:
https://doaj.org/article/2bdc601bca714a0096f7897cf6b51d33
Autor:
Philipp Gulde, Peter Rieckmann
Publikováno v:
JMIR Rehabilitation and Assistive Technologies, Vol 9, Iss 1, p e31164 (2022)
BackgroundPersons with multiple sclerosis frequently report increased levels of fatigue and fatigability. However, behavioral surrogates that are strongly associated with self-reports are lacking, which limits research and treatment. ObjectiveThe ai
Externí odkaz:
https://doaj.org/article/8838b650fac04757bf7e7100df18738b
Autor:
Mohamed AlJumah, Mona Marwan Alkhawajah, Shireen Qureshi, Ibtisam Al-Thubaiti, Omar Ayoub, Saeed A. Bohlega, Areej Bushnag, Edward Cupler, Abdulkader Daif, Ahmed El Boghdady, Ahmed Hassan, Yaser Al Malik, Jameelah Saeedi, Fawzia Al-Shamrany, Eslam Shosha, Peter Rieckmann
Publikováno v:
Neurology and Therapy, Vol 9, Iss 1, Pp 11-23 (2020)
Abstract Immune reconstitution therapy (IRT) is an emerging management concept for multiple sclerosis, whereby a short course of treatment provides long-lasting suppression of disease activity. “Cladribine tablets 10 mg” refers to a total cumulat
Externí odkaz:
https://doaj.org/article/cd655620213b486c8bfdbc2a1877ed46
Autor:
Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H. Hua, Celia Oreja-Guevara, Daniel Selchen, Per Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh, Bassem Yamout
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Background: Gaps in current evidence and guidance leave clinicians with unanswered questions on the use of cladribine tablets for the treatment of multiple sclerosis (MS) in the era of the COVID-19 pandemic, in particular relating to COVID-19 vaccina
Externí odkaz:
https://doaj.org/article/e93636f89bdc48f2b139203c90ec96a4
Autor:
Heinz Wiendl, Ralf Gold, Thomas Berger, Tobias Derfuss, Ralf Linker, Mathias Mäurer, Orhan Aktas, Karl Baum, Martin Berghoff, Stefan Bittner, Andrew Chan, Adam Czaplinski, Florian Deisenhammer, Franziska Di Pauli, Renaud Du Pasquier, Christian Enzinger, Elisabeth Fertl, Achim Gass, Klaus Gehring, Claudio Gobbi, Norbert Goebels, Michael Guger, Aiden Haghikia, Hans-Peter Hartung, Fedor Heidenreich, Olaf Hoffmann, Boris Kallmann, Christoph Kleinschnitz, Luisa Klotz, Verena I. Leussink, Fritz Leutmezer, Volker Limmroth, Jan D. Lünemann, Andreas Lutterotti, Sven G. Meuth, Uta Meyding-Lamadé, Michael Platten, Peter Rieckmann, Stephan Schmidt, Hayrettin Tumani, Frank Weber, Martin S. Weber, Uwe K. Zettl, Tjalf Ziemssen, Frauke Zipp
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Multiple sclerosis is a complex, autoimmune-mediated disease of the central nervous system characterized by inflammatory demyelination and axonal/neuronal damage. The approval of various disease-modifying therapies and our increased understanding of
Externí odkaz:
https://doaj.org/article/cee55fa870514dd8bb41f4326e4ce63e
Publikováno v:
Neurology and Therapy, Vol 7, Iss 2, Pp 179-187 (2018)
Abstract A debate on shared decision making in multiple sclerosis (MS) was led by a patient advocate and leading neurologists from the MS in the 21st Century Steering Group. Key themes and salient points which emerged from the debate and audience dis
Externí odkaz:
https://doaj.org/article/5f0e8d0968ca4e1795a8282753129c2c
Publikováno v:
Multiple Sclerosis International, Vol 2021 (2021)
Introduction. Improved gait is one of the leading therapy goals in multiple sclerosis. A plethora of clinical timed trials and state-of-the-art technology-based approaches are available to assess gait performance. Objectives. To examine what aspects
Externí odkaz:
https://doaj.org/article/4129d10506604f48b4d74fe6ccc712d4